Epstein-Barr virus nuclear antigen 2 retards cell growth, induces p21WAF1 expression, and modulates p53 activity post-translationally
- 13 October 2000
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 303 (1) , 7-23
- https://doi.org/10.1006/jmbi.2000.4121
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinasesOncogene, 1998
- p53 phosphorylation: Biochemical and functional consequencesLife Sciences, 1996
- Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNACell, 1996
- p53 in growth control and neoplasiaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Epstein--Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein--Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma linesJournal of General Virology, 1996
- Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinasesNature, 1995
- Phosphorylation Studies on Rat p53 Using the Baculovirus Expression SystemEuropean Journal of Biochemistry, 1995
- Mediation of Epstein-Barr Virus EBNA2 Transactivation by Recombination Signal-Binding Protein J κScience, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993